Clinical Trial Update: Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating filgotinib for induction and maintenance of remission in adults with moderately to severely active Crohn's disease has completed with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Filgotinib (filgotinib)

Snippet

Sponsor: Galapagos NV | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2023-12-18